Buy Calliditas Therapeutics AB Stock | CALT Stock Price & Latest News | Public.com

CALT

Calliditas Therapeutics AB

$0.00 (0.00%)Today

    About CALT

    Calliditas Therapeutics AB provides pharmaceutical products for patients with niche indications. It focuses on development and commercialization of the product candidate Nefecon intended for treatment of patients with the inflammatory renal disease IgA nephropathy. The ...Read more

    Community

    People who own or watch this stock

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Price Targets

    What analysts think this stock will be worth

    $23.96
    current
    $0.00
    average

    Events

    List of events that could affect this stock.

    13Aug

    Earnings data Q2 2020

    Stats

    Market Cap$584,53M
    Volume103
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$24.97
    1 Year Low$19.00
    Open$23.92
    High$23.96
    Low$23.85

    Buy any stock with any amount of money.

    Download the App
    Download the app